Use of docetaxel (Taxotere®) in patients with paclitaxel (Taxol®) hypersensitivity

被引：32
|
作者：
Moon, C [1 ]
Verschraegen, CF [1 ]
Bevers, M [1 ]
Freedman, R [1 ]
Kudelka, AP [1 ]
Kavanagh, JJ [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Dept Internal Med Specialities, Sect Gynecol & Med Therapeut, Houston, TX 77030 USA
来源：
ANTI-CANCER DRUGS | 2000年 / 11卷 / 07期
关键词：
allergic reactions; ovarian neoplasms; taxane;
D O I：
10.1097/00001813-200008000-00007
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Anaphylaxis or significant hypersensitivity reaction is one of the most catastrophic potential complications of chemotherapy. There is a 2-5% risk of hypersensitivity with paclitaxel, a commonly used chemotherapeutic agent for various cancers. Three patients, who developed hypersensitivity to paclitaxel infusion, received docetaxel without allergic reactions. Docetaxel may therefore be an alternative treatment for patients with paclitaxel hypersensitivity. [(C) 2000 Lippincott Williams & Wilkins].
引用
收藏
页码：565 / 568
页数：4
相关论文
共 50 条
  • [21] Docetaxel Taxotere® -: Oncolytic
    不详
    DRUGS OF THE FUTURE, 2000, 25 (05) : 514 - 515
  • [22] Weekly docetaxel (Taxotere®) in patients with metastatic breast cancer
    Stemmler, HJ
    Gutschow, K
    Sommer, H
    Malekmohammadi, M
    Kentenich, C
    Forstpointner, R
    Geuenich, S
    Bischoff, J
    Hiddemann, W
    Heinemann, V
    ANNALS OF ONCOLOGY, 2001, 12 (10) : 1393 - 1398
  • [23] Optimal use of docetaxel (Taxotere(R)): Maximizing its potential
    Burris, HA
    ANTI-CANCER DRUGS, 1996, 7 : 25 - 28
  • [24] MOTOR NEUROPATHY DUE TO TAXOTERE AND TAXOL
    FREILICH, RJ
    BALMACEDA, C
    RUBIN, M
    DEANGELIS, LM
    NEUROLOGY, 1994, 44 (04) : A217 - A217
  • [25] Hypersensitivity reaction (HSR) to docetaxel after a previous HSR to paclitaxel
    Denman, JP
    Gilbar, PJ
    Abdi, EA
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (11) : 2760 - 2761
  • [26] USE OF TAXOL (PACLITAXEL) IN BREAST-CANCER
    HORTOBAGYI, GN
    HOLMES, FA
    THERIAULT, RL
    BUZDAR, AU
    ONCOLOGY, 1994, 51 : 29 - 32
  • [27] Docetaxel (Taxotere) in the treatment of cancer
    Burris, HA
    SEMINARS IN ONCOLOGY, 2000, 27 (02) : 1 - 2
  • [28] PRECLINICAL EVALUATION OF DOCETAXEL (TAXOTERE)
    LAVELLE, F
    BISSERY, MC
    COMBEAU, C
    RIOU, JF
    VRIGNAUD, P
    ANDRE, S
    SEMINARS IN ONCOLOGY, 1995, 22 (02) : 3 - 16
  • [29] PACLITAXEL (TAXOL)
    KOHLER, DR
    GOLDSPIEL, BR
    PHARMACOTHERAPY, 1994, 14 (01): : 3 - 34
  • [30] NEW FAMILY OF TAXOL, TAXOTERE ANALOGS DEVELOPED
    BORMAN, S
    CHEMICAL & ENGINEERING NEWS, 1993, 71 (15) : 36 - 37
12345